The AlphaLISA™ SureFire® Ultra™ Human and Mouse Total DDR2 assay is a sandwich immunoassay for quantitative detection of total DDR2 in cellular lysates using Alpha Technology.
| Feature | Specification |
|---|---|
| Application | 細胞シグナル伝達 |
| Protocol Time | 2h at RT |
| Sample Volume | 10 µL |
The AlphaLISA™ SureFire® Ultra™ Human and Mouse Total DDR2 assay is a sandwich immunoassay for quantitative detection of total DDR2 in cellular lysates using Alpha Technology.
Discoidin Domain Receptor 2 (DDR2) is a receptor tyrosine kinase activated by fibrillar collagens in the extracellular matrix, particularly collagen types I, II, and III. DDR2 regulates cell adhesion, migration, proliferation, and matrix metalloproteinase (MMP) expression, playing crucial roles in tissue development, wound healing, and fibrosis. Upon collagen binding, DDR2 undergoes sustained autophosphorylation and activates downstream signaling through MAPK, PI3K/AKT, and Src pathways. Mutations and overexpression of DDR2 are implicated in various cancers, including lung squamous cell carcinoma, breast cancer, and head and neck cancers, where it promotes invasion, metastasis, and drug resistance. DDR2 is also associated with fibrotic diseases and skeletal disorders. Emerging therapeutic strategies target DDR2 to inhibit tumor progression and reduce pathological fibrosis.
The AlphaLISA SureFire Ultra Human and Mouse Total DDR2 is a sandwich immunoassay for the quantitative detection of total DDR2 in cellular lysates, using Alpha Technology.
Formats:
AlphaLISA SureFire Ultra kits are compatible with:
AlphaLISA SureFire Ultra kits can be used for:
The Total-AlphaLISA SureFire Ultra assay measures the expression level of a protein target in a cell lysate.
The Total-AlphaLISA SureFire Ultra assay uses two antibodies which recognize two different distal epitopes on the targeted protein. AlphaLISA assays require two bead types: Acceptor and Donor beads. Acceptor beads are coated with a proprietary CaptSure™ agent to specifically immobilize the assay specific antibody, labeled with a CaptSure tag. Donor beads are coated with streptavidin to capture one of the detection antibodies, which is biotinylated. In the presence of targeted protein, the two antibodies bring the Donor and Acceptor beads in close proximity whereby the singlet oxygen transfers energy to excite the Acceptor bead, allowing the generation of a luminescent Alpha signal. The amount of light emission is directly proportional to the quantity of protein present in the sample.
The two-plate protocol involves culturing and treating the cells in a 96-well plate before lysis, then transferring lysates into a 384-well OptiPlate™ plate before the addition of Total-AlphaLISA SureFire Ultra detection reagents. This protocol permits the cells viability and confluence to be monitored. In addition, lysates from a single well can be used to measure multiple targets.
Detection of Total target protein with AlphaLISA SureFire Ultra reagents can be performed in a single plate used for culturing, treatment, and lysis. No washing steps are required. This HTS designed protocol allows for miniaturization while maintaining AlphaLISA SureFire Ultra quality.
HT-1080 cells were seeded in a 96-well plate (60,000 cells/well) in complete medium and incubated overnight at 37°C, 5% CO2. The cells were treated with 100 µg/mL of Collagen I (derived from rat tail) for indicated times.
After treatment, the cells were lysed with 50 µL of Lysis Buffer B for 10 minutes at RT with shaking (350 rpm). DDR2 Phospho (Tyr740) and Total levels were evaluated using respective AlphaLISA SureFire Ultra assays. For the detection step, 10 µL of cell lysate (approximately 12,000 cells) was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at RT. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.
As expected, Collagen I triggered a time dependent increase in the levels of Phospho DDR2 (Tyr740) with no change to the Total DDR2 levels.
HT-1080 cells were seeded in a 96-well plate (60,000 cells/well) in complete medium and incubated overnight at 37°C, 5% CO2. The cells were treated with increasing concentrations of Collagen I (derived from rat tail) for 4 hours.
After treatment, the cells were lysed with 50 µL of Lysis Buffer B for 10 minutes at RT with shaking (350 rpm). DDR2 Phospho (Tyr740) and Total levels were evaluated using respective AlphaLISA SureFire Ultra assays. For the detection step, 10 µL of cell lysate (approximately 12,000 cells) was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at RT. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.
Collagen I treatment triggered a dose-dependent increase in the levels of Phospho DDR2 (Tyr740) with no change to the Total DDR2 levels.
RD and C2C12 cells were seeded in a 96-well plate (50,000 cells/well) in complete medium and incubated overnight at 37°C, 5% CO2. The cells were treated with increasing concentrations of pervanadate for 30 minutes.
After treatment, the cells were lysed with 50 µL of Lysis Buffer B for 10 minutes at RT with shaking (350 rpm). DDR2 Phospho (Tyr740) and Total levels were evaluated using respective AlphaLISA SureFire Ultra assays. For the detection step, 10 µL of cell lysate (approximately 10,000 cells) was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at RT. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.
As expected, pervanadate triggered a dose-dependent increase in the levels of Phospho DDR2 (Tyr740) while total levels remained unchanged.
HT-1080 cells were seeded in a 96-well plate (50,000 cells/well) in complete medium and incubated overnight at 37°C, 5% CO2. The cells were treated for 2 hours with increasing concentrations of Dasatinib, all media was removed and then followed by treatment with 100 µg/mL Collagen I (derived from rat tail) for 4 hours.
After treatment, the cells were lysed with 50 µL of Lysis Buffer B for 10 minutes at RT with shaking (350 rpm). DDR2 Phospho (Tyr740) and Total levels were evaluated using respective AlphaLISA SureFire Ultra assays. For the detection step, 10 µL of cell lysate (approximately 10,000 cells) was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at RT. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.
As expected, Dasatinib triggered a dose-dependent decrease in the levels of Phospho DDR2 (Tyr740) while total levels remained unchanged.
Expression of DDR2 and DDR1 was evaluated in various cell lines using the AlphaLISA SureFire Ultra assay kit.
For the detection step, 10 µL of lysate (approximately 50,000 cells) was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at room temperature. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.
A significant difference in expression profiles was observed between DDR2 and DDR1. As expected, DDR2 was only detected in RD and SH-SY5Y cells while DDR1 expression was observed across various cell lines.
| Application |
Cell Signaling
|
|---|---|
| Automation Compatible |
Yes
|
| Brand |
AlphaLISA SureFire Ultra
|
| Detection Modality |
Alpha
|
| Product Group |
Kit
|
| Protocol Time |
2h at RT
|
| Sample Volume |
10 µL
|
| Shipping Conditions |
Shipped in Blue Ice
|
| Target |
DDR2
|
| Target Class |
Phosphoproteins
|
| Target Species |
Human
Mouse
|
| Technology |
Alpha
|
| Therapeutic Area |
NASH/Fibrosis
Oncology
|
| Unit Size |
10,000 assay points
|
Are you looking for resources, click on the resource type to explore further.
Alpha technolgy enables the rapid and straightforward mesaure of virtually any target. This includes enzymes, receptor-ligand...
Discover Alpha SureFire® Ultra™ assays, the no-wash cellular kinase assays leveraging Revvity's exclusive bead-based technology...
This document includes detailed tables listing HTRF™, AlphaLISA™ SureFire® Ultra™, and Alpha SureFire® Ultra™ Multiplex assays...
We are here to answer your questions.